Recombinant Human IL-17F protein (Active)
- Premium Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human IL-17F protein (Active) is a Human Full Length protein, in the 31 to 163 aa range, expressed in HEK 293 cells, with >95%, <0.005 EU/µg endotoxin level, suitable for SDS-PAGE, Mass Spec, HPLC, FuncS.
View Alternative Names
Interleukin-17F, IL-17F, Cytokine ML-1, IL17F
- Biochemical assay
Supplier Data
Biochemical assay - Recombinant Human IL-17F protein (Active) (AB283921)
Fully biologically active determined by the dose dependent NF-kb activation in mouse RAW264.7 NF-kb reporter cell line in presence of TNF alpha. ED50 is ≤ 3.4 ng/ml, corresponding to a specific activity of 2.94 x 105 units/mg.
- Mass Spec
Lab
Mass Spectrometry - Recombinant Human IL-17F protein (Active) (AB283921)
Mass determination by ESI-TOF.
Predicted MW is 14960.15 (+/- 10 Da by ESI TOF). Observed MW is 14961.57 Da.
- SDS-PAGE
Lab
SDS-PAGE - Recombinant Human IL-17F protein (Active) (AB283921)
SDS-PAGE analysis of ab283921.
- HPLC
Lab
HPLC - Recombinant Human IL-17F protein (Active) (AB283921)
HPLC analysis of ab283921
Reactivity data
Sequence info
Properties and storage information
Form
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
General info
Function
Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed : 21350122). IL17A-IL17F signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation (PubMed : 11574464, PubMed : 11591732, PubMed : 11591768, PubMed : 17911633, PubMed : 18684971, PubMed : 21350122, PubMed : 28827714). IL17A-IL17F is primarily involved in host defense against extracellular bacteria and fungi by inducing neutrophilic inflammation (By similarity). As signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites (By similarity). Stimulates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (By similarity). IL17F homodimer can signal via IL17RC homodimeric receptor complex, triggering downstream activation of TRAF6 and NF-kappa-B signaling pathway (PubMed : 32187518). Via IL17RC induces transcriptional activation of IL33, a potent cytokine that stimulates group 2 innate lymphoid cells and adaptive T-helper 2 cells involved in pulmonary allergic response to fungi. Likely via IL17RC, promotes sympathetic innervation of peripheral organs by coordinating the communication between gamma-delta T cells and parenchymal cells. Stimulates sympathetic innervation of thermogenic adipose tissue by driving TGFB1 expression (By similarity). Regulates the composition of intestinal microbiota and immune tolerance by inducing antimicrobial proteins that specifically control the growth of commensal Firmicutes and Bacteroidetes (By similarity).
Sequence similarities
Belongs to the IL-17 family.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com